<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01251042</url>
  </required_header>
  <id_info>
    <org_study_id>YA-DRA-0006</org_study_id>
    <nct_id>NCT01251042</nct_id>
  </id_info>
  <brief_title>Comparison Between Return and Wastage of Your Own Blood, Collected During Spinal Surgery, for Verification of Safety When Returning Blood</brief_title>
  <official_title>A Prospective, Randomized, Controlled Study on Intra-operative Autologous Transfusion With the Sangvia® Blood Salvage System in Spinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wellspect HealthCare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wellspect HealthCare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is an open, randomized, controlled, single-centre study including a total of 42
      evaluable subjects scheduled for spinal surgery with an approximate expected bleeding of
      800-1500 ml. The Sangvia® Blood Salvage System will be set up for all subjects to collect
      blood intra-operatively. When the transfusion bag is filled, i.e. when around 500 ml of blood
      has been collected, the subject will be randomized to either be retransfused with the blood
      collected (investigational group) or not (control group). The primary objective for this
      study is to investigate the blood quality and isolate the systemic effects in
      intra-operatively collected blood. The systemic p-Hb concentration has been chosen as the
      primary outcome variable based on previous experience and literature and is considered as the
      major safety concern for the study subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Plasma Free Hemoglobin (p-Hb) Concentration</measure>
    <time_frame>At screening and 24 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Difference in plasma free hemoglobin (p-Hb) concentration between screening and 24 hours after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma Free Hemoglobin (p-Hb) Concentration</measure>
    <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Systemic plasma free hemoglobin (p-Hb) concentration from screening until 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin Concentration</measure>
    <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Systemic hemoglobin concentration from screening until 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potassium Concentration</measure>
    <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Systemic potassium concentration from screening until 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine Concentration</measure>
    <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Systemic creatinine concentration from screening until 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-1-alpha (IL-1-α) Concentration</measure>
    <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Systemic IL-1-α concentration from screening until 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-6 (IL-6) Concentration</measure>
    <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Systemic IL-6 concentration from screening until 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-8 (IL-8) Concentration</measure>
    <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Systemic IL-8 concentration from screening until 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-10 (IL-10) Concentration</measure>
    <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Systemic IL-10 concentration from screening until 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor Necrosis Factor Alpha (TNF-α) Concentration</measure>
    <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Systemic TNF-α concentration from screening until 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interferon Gamma (IFN-γ) Concentration</measure>
    <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Systemic IFN-γ concentration from screening until 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Blood Loss Volume</measure>
    <time_frame>After surgery (surgery takes place 1-7 days after screening)</time_frame>
    <description>Estimated blood loss during and after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of Allogenic Blood Transfusion</measure>
    <time_frame>Up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Spinal Surgery</condition>
  <arm_group>
    <arm_group_label>Sangvia and retransfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sangvia and no retransfusion</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sangvia</intervention_name>
    <description>The Sangvia® Blood Salvage System used to collect blood intra-operatively.</description>
    <arm_group_label>Sangvia and retransfusion</arm_group_label>
    <arm_group_label>Sangvia and no retransfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provision of informed consent.

          -  Male and female subjects aged 18 years and over subjected to spinal surgery with an
             approximate expected bleeding of 800-1500 ml.

          -  Subjects classified as ASA Physical Status Classification System class P1, P2 or P3
             according to the American Society of Anaesthesiology.

        Exclusion Criteria:

          -  Involvement in the planning and conduct of the study (applies to both Astra Tech staff
             or staff at the study site).

          -  Previous enrolment or randomisation of treatment in the present study.

          -  Participation in another clinical study, that may interfere with the present study.

          -  Severe non-compliance to protocol as judged by the investigator and/or Astra Tech.

          -  Haemophilia.

          -  Hyperkalemia (i.e. values above the normal reference values at study site).

          -  Symptoms of impaired renal function including creatinine clearance levels (using the
             Cockcroft-Gault formula) &lt;30 ml/min.

          -  Malignancy in the area of the operative site.

          -  Current or expected use of cytotoxic drugs.

          -  Symptoms of systemic infection or local infection in the operation field.

          -  Pregnancy.

          -  Sickle cell anaemia and/or pre-operative Hb concentration &lt;11 g/dl (6,8 mmol/l).

          -  Use of recombinant erythropoietin (EPO) or fibrin sealant.

          -  Use of other autologous blood transfusion than with the Sangvia® system (e.g.
             CellSaver and pre-donation) or other blood saving techniques (e.g. normovolemic
             hemodilution).

          -  Hypotensive anesthesia.

          -  Use of antithrombotic medication within 5 days of surgery (NSAID, Clopidogrel).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Rud Lassen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup Hospital, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Trial Unit, Glostrup Hospital, University of Copenhagen</name>
      <address>
        <city>Glostrup</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2010</study_first_submitted>
  <study_first_submitted_qc>November 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2010</study_first_posted>
  <results_first_submitted>March 12, 2013</results_first_submitted>
  <results_first_submitted_qc>March 12, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 24, 2013</results_first_posted>
  <last_update_submitted>April 29, 2013</last_update_submitted>
  <last_update_submitted_qc>April 29, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>51 subjects were enrolled but 2 subjects were never randomized and have thus not been included in the analysis.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sangvia and Retransfusion</title>
          <description>Blood collected and retransfused with Sangvia.</description>
        </group>
        <group group_id="P2">
          <title>Sangvia and no Retransfusion</title>
          <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sangvia and Retransfusion</title>
          <description>Blood collected and retransfused with Sangvia.</description>
        </group>
        <group group_id="B2">
          <title>Sangvia and no Retransfusion</title>
          <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="23"/>
            <count group_id="B3" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53" spread="14"/>
                    <measurement group_id="B2" value="59" spread="13"/>
                    <measurement group_id="B3" value="56" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Plasma Free Hemoglobin (p-Hb) Concentration</title>
        <description>Systemic plasma free hemoglobin (p-Hb) concentration from screening until 96 hours after surgery.</description>
        <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Free Hemoglobin (p-Hb) Concentration</title>
          <description>Systemic plasma free hemoglobin (p-Hb) concentration from screening until 96 hours after surgery.</description>
          <population>All subjects randomized.</population>
          <units>g/l</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.2" lower_limit="-0.0288" upper_limit="0.1208"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Randomization (0 hrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.2"/>
                    <measurement group_id="O2" value="0.2" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.7"/>
                    <measurement group_id="O2" value="NA">Time point End of transfusion only applicable to subjects in the investigational group (Sangvia and retransfusion).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.7"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.1"/>
                    <measurement group_id="O2" value="0.0" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.2"/>
                    <measurement group_id="O2" value="01." spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hemoglobin Concentration</title>
        <description>Systemic hemoglobin concentration from screening until 96 hours after surgery.</description>
        <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Hemoglobin Concentration</title>
          <description>Systemic hemoglobin concentration from screening until 96 hours after surgery.</description>
          <population>All subjects randomized.</population>
          <units>g/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.2" spread="1.1"/>
                    <measurement group_id="O2" value="13.8" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Randomization (0 hrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.8" spread="1.1"/>
                    <measurement group_id="O2" value="11.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5" spread="1.1"/>
                    <measurement group_id="O2" value="NA">Time point End of transfusion only applicable to subjects in the investigational group (Sangvia and retransfusion).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5" spread="1.1"/>
                    <measurement group_id="O2" value="11.6" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.4" spread="1.2"/>
                    <measurement group_id="O2" value="11.5" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.6" spread="1.2"/>
                    <measurement group_id="O2" value="10.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.4" spread="1.0"/>
                    <measurement group_id="O2" value="10.8" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.2" spread="1.3"/>
                    <measurement group_id="O2" value="10.9" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Potassium Concentration</title>
        <description>Systemic potassium concentration from screening until 96 hours after surgery.</description>
        <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Potassium Concentration</title>
          <description>Systemic potassium concentration from screening until 96 hours after surgery.</description>
          <population>All subjects randomized.</population>
          <units>mmol/l</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="0.3"/>
                    <measurement group_id="O2" value="4.4" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Randomization (0 hrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="0.4"/>
                    <measurement group_id="O2" value="4.1" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="0.4"/>
                    <measurement group_id="O2" value="NA">Time point End of transfusion only applicable to subjects in the investigational group (Sangvia and retransfusion).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="0.4"/>
                    <measurement group_id="O2" value="4.3" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="0.5"/>
                    <measurement group_id="O2" value="4.3" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="0.3"/>
                    <measurement group_id="O2" value="4.0" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="0.6"/>
                    <measurement group_id="O2" value="4.0" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="0.4"/>
                    <measurement group_id="O2" value="4.0" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Creatinine Concentration</title>
        <description>Systemic creatinine concentration from screening until 96 hours after surgery.</description>
        <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Creatinine Concentration</title>
          <description>Systemic creatinine concentration from screening until 96 hours after surgery.</description>
          <population>All subjects randomized.</population>
          <units>μmol/l</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64" spread="13"/>
                    <measurement group_id="O2" value="70" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Randomization (0 hrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" spread="12"/>
                    <measurement group_id="O2" value="69" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68" spread="13"/>
                    <measurement group_id="O2" value="NA">Time point End of transfusion only applicable to subjects in the investigational group (Sangvia and retransfusion).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66" spread="12"/>
                    <measurement group_id="O2" value="72" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" spread="12"/>
                    <measurement group_id="O2" value="64" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" spread="12"/>
                    <measurement group_id="O2" value="66" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" spread="12"/>
                    <measurement group_id="O2" value="67" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59" spread="12"/>
                    <measurement group_id="O2" value="64" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Difference in Plasma Free Hemoglobin (p-Hb) Concentration</title>
        <description>Difference in plasma free hemoglobin (p-Hb) concentration between screening and 24 hours after surgery</description>
        <time_frame>At screening and 24 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Plasma Free Hemoglobin (p-Hb) Concentration</title>
          <description>Difference in plasma free hemoglobin (p-Hb) concentration between screening and 24 hours after surgery</description>
          <population>All subjects randomized.</population>
          <units>g/l</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.2"/>
                    <measurement group_id="O2" value="0.0" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Information about the size of the standard deviation (SD) for the change was obtained from an earlier study. The SD for the change from pre-operation until 24 hours after start of transfusion was 0.2305. Due to the imprecise measuring device (if values below 0.3 g/l) and the large SD, a non-inferiority margin (∆) of 0.2 g/l was decided to be used in this study, resulting in a total number of 42 evaluable subjects, i.e. 21 subjects per group.</non_inferiority_desc>
            <p_value>0.6294</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Interleukin-1-alpha (IL-1-α) Concentration</title>
        <description>Systemic IL-1-α concentration from screening until 96 hours after surgery.</description>
        <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Interleukin-1-alpha (IL-1-α) Concentration</title>
          <description>Systemic IL-1-α concentration from screening until 96 hours after surgery.</description>
          <population>All subjects randomized.</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.36" spread="24.14"/>
                    <measurement group_id="O2" value="23.44" spread="36.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Randomization (0 hrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.66" spread="18.37"/>
                    <measurement group_id="O2" value="22.39" spread="37.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.97" spread="16.21"/>
                    <measurement group_id="O2" value="NA">Time point End of transfusion only applicable to subjects in the investigational group (Sangvia and retransfusion).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.04" spread="17.17"/>
                    <measurement group_id="O2" value="26.69" spread="51.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.45" spread="14.26"/>
                    <measurement group_id="O2" value="22.16" spread="34.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.63" spread="15.06"/>
                    <measurement group_id="O2" value="15.74" spread="14.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.44" spread="16.15"/>
                    <measurement group_id="O2" value="17.41" spread="14.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Interleukin-6 (IL-6) Concentration</title>
        <description>Systemic IL-6 concentration from screening until 96 hours after surgery.</description>
        <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Interleukin-6 (IL-6) Concentration</title>
          <description>Systemic IL-6 concentration from screening until 96 hours after surgery.</description>
          <population>All subjects randomized.</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.35" spread="9.38"/>
                    <measurement group_id="O2" value="8.94" spread="10.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Randomization (0 hrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.27" spread="6.12"/>
                    <measurement group_id="O2" value="9.71" spread="9.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.30" spread="46.00"/>
                    <measurement group_id="O2" value="NA">Time point End of transfusion only applicable to subjects in the investigational group (Sangvia and retransfusion).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.29" spread="87.34"/>
                    <measurement group_id="O2" value="64.20" spread="93.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116.65" spread="171.29"/>
                    <measurement group_id="O2" value="118.89" spread="192.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118.05" spread="163.19"/>
                    <measurement group_id="O2" value="163.73" spread="188.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.14" spread="24.00"/>
                    <measurement group_id="O2" value="32.51" spread="19.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Interleukin-8 (IL-8) Concentration</title>
        <description>Systemic IL-8 concentration from screening until 96 hours after surgery.</description>
        <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Interleukin-8 (IL-8) Concentration</title>
          <description>Systemic IL-8 concentration from screening until 96 hours after surgery.</description>
          <population>All subjects randomized.</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.35" spread="1.07"/>
                    <measurement group_id="O2" value="1.35" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Randomization (0 hrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.34" spread="2.67"/>
                    <measurement group_id="O2" value="2.01" spread="2.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.32" spread="6.41"/>
                    <measurement group_id="O2" value="NA">Time point End of transfusion only applicable to subjects in the investigational group (Sangvia and retransfusion).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.17" spread="9.14"/>
                    <measurement group_id="O2" value="2.91" spread="2.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.05" spread="1.53"/>
                    <measurement group_id="O2" value="3.13" spread="2.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.57" spread="2.27"/>
                    <measurement group_id="O2" value="3.77" spread="2.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.48" spread="1.96"/>
                    <measurement group_id="O2" value="2.70" spread="1.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Interleukin-10 (IL-10) Concentration</title>
        <description>Systemic IL-10 concentration from screening until 96 hours after surgery.</description>
        <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Interleukin-10 (IL-10) Concentration</title>
          <description>Systemic IL-10 concentration from screening until 96 hours after surgery.</description>
          <population>All subjects randomized.</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.25" spread="2.72"/>
                    <measurement group_id="O2" value="2.07" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Randomization (0 hrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.59" spread="3.44"/>
                    <measurement group_id="O2" value="7.99" spread="9.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.65" spread="100.88"/>
                    <measurement group_id="O2" value="NA">Time point End of transfusion only applicable to subjects in the investigational group (Sangvia and retransfusion).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.60" spread="81.04"/>
                    <measurement group_id="O2" value="18.36" spread="18.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.29" spread="4.26"/>
                    <measurement group_id="O2" value="4.27" spread="2.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.54" spread="1.48"/>
                    <measurement group_id="O2" value="4.96" spread="3.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.15" spread="1.34"/>
                    <measurement group_id="O2" value="2.67" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tumor Necrosis Factor Alpha (TNF-α) Concentration</title>
        <description>Systemic TNF-α concentration from screening until 96 hours after surgery.</description>
        <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Tumor Necrosis Factor Alpha (TNF-α) Concentration</title>
          <description>Systemic TNF-α concentration from screening until 96 hours after surgery.</description>
          <population>All subjects randomized.</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.40" spread="52.70"/>
                    <measurement group_id="O2" value="15.42" spread="34.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Randomization (0 hrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.14" spread="30.51"/>
                    <measurement group_id="O2" value="13.87" spread="28.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.43" spread="28.41"/>
                    <measurement group_id="O2" value="NA">Time point End of transfusion only applicable to subjects in the investigational group (Sangvia and retransfusion).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.23" spread="28.25"/>
                    <measurement group_id="O2" value="14.02" spread="28.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.55" spread="23.60"/>
                    <measurement group_id="O2" value="7.86" spread="17.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.84" spread="24.05"/>
                    <measurement group_id="O2" value="7.69" spread="15.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.37" spread="20.56"/>
                    <measurement group_id="O2" value="5.49" spread="7.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Interferon Gamma (IFN-γ) Concentration</title>
        <description>Systemic IFN-γ concentration from screening until 96 hours after surgery.</description>
        <time_frame>At screening and up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Interferon Gamma (IFN-γ) Concentration</title>
          <description>Systemic IFN-γ concentration from screening until 96 hours after surgery.</description>
          <population>All subjects randomized.</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Screening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.45" spread="14.17"/>
                    <measurement group_id="O2" value="8.61" spread="18.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Randomization (0 hrs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.89" spread="5.35"/>
                    <measurement group_id="O2" value="7.37" spread="15.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.50" spread="4.24"/>
                    <measurement group_id="O2" value="NA">Time point End of transfusion only applicable to subjects in the investigational group (Sangvia and retransfusion).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.54" spread="5.15"/>
                    <measurement group_id="O2" value="8.31" spread="19.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.94" spread="3.12"/>
                    <measurement group_id="O2" value="7.98" spread="16.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.00" spread="3.49"/>
                    <measurement group_id="O2" value="5.94" spread="7.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.25" spread="3.60"/>
                    <measurement group_id="O2" value="7.14" spread="7.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Blood Loss Volume</title>
        <description>Estimated blood loss during and after surgery.</description>
        <time_frame>After surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Blood Loss Volume</title>
          <description>Estimated blood loss during and after surgery.</description>
          <population>All subjects randomized.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Intra-operative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="623" spread="444" lower_limit="150" upper_limit="2400"/>
                    <measurement group_id="O2" value="742" lower_limit="200" upper_limit="2400"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-operative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="392" lower_limit="0" upper_limit="1150"/>
                    <measurement group_id="O2" value="420" lower_limit="120" upper_limit="1525"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1015" lower_limit="150" upper_limit="3150"/>
                    <measurement group_id="O2" value="1162" lower_limit="350" upper_limit="2800"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Frequency of Allogenic Blood Transfusion</title>
        <time_frame>Up until 96 hours after surgery (surgery takes place 1-7 days after screening)</time_frame>
        <population>All subjects randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Sangvia and Retransfusion</title>
            <description>Blood collected and retransfused with Sangvia.</description>
          </group>
          <group group_id="O2">
            <title>Sangvia and no Retransfusion</title>
            <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
          </group>
        </group_list>
        <measure>
          <title>Frequency of Allogenic Blood Transfusion</title>
          <population>All subjects randomized.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Sangvia and Retransfusion</title>
          <description>Blood collected and retransfused with Sangvia.</description>
        </group>
        <group group_id="E2">
          <title>Sangvia and no Retransfusion</title>
          <description>Blood collected with Sangvia but discarded, i.e. not retransfused.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Wound oozing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Campylobacter infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Leg pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Nerve contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchial spasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="26"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="26"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="26"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Decreased hemoglobin</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Leg pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="26"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Emma Tällberg, Clinical Research Manager</name_or_title>
      <organization>Wellspect HealthCare</organization>
      <phone>+46313764000</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

